Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Therapeutic Vaccines Market Research Report 2019-2025

Buy now

Table of Contents

    1 Therapeutic Vaccines Market Overview

    • 1.1 Product Overview and Scope of Therapeutic Vaccines
    • 1.2 Therapeutic Vaccines Segment by Type
      • 1.2.1 Global Therapeutic Vaccines Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Peptide Therapeutic Vaccine
      • 1.2.3 Cell Therapeutic Vaccine
      • 1.2.4 Nucleic Acid Therapeutic Vaccine
    • 1.3 Therapeutic Vaccines Segment by Application
      • 1.3.1 Therapeutic Vaccines Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Oncotherapy
      • 1.3.3 Hepatitis B
      • 1.3.4 Tuberculosis
      • 1.3.5 Herpes Simplex Virus
      • 1.3.6 Others
    • 1.4 Global Therapeutic Vaccines Market Size Estimates and Forecasts
      • 1.4.1 Global Therapeutic Vaccines Revenue 2015-2026
      • 1.4.2 Global Therapeutic Vaccines Sales 2015-2026
      • 1.4.3 Therapeutic Vaccines Market Size by Region: 2020 Versus 2026

    2 Global Therapeutic Vaccines Market Competition by Manufacturers

    • 2.1 Global Therapeutic Vaccines Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global Therapeutic Vaccines Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global Therapeutic Vaccines Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers Therapeutic Vaccines Manufacturing Sites, Area Served, Product Type
    • 2.5 Therapeutic Vaccines Market Competitive Situation and Trends
      • 2.5.1 Therapeutic Vaccines Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key Therapeutic Vaccines Players (Opinion Leaders)

    3 Therapeutic Vaccines Retrospective Market Scenario by Region

    • 3.1 Global Therapeutic Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global Therapeutic Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America Therapeutic Vaccines Market Facts & Figures by Country
      • 3.3.1 North America Therapeutic Vaccines Sales by Country
      • 3.3.2 North America Therapeutic Vaccines Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Therapeutic Vaccines Market Facts & Figures by Country
      • 3.4.1 Europe Therapeutic Vaccines Sales by Country
      • 3.4.2 Europe Therapeutic Vaccines Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Therapeutic Vaccines Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Therapeutic Vaccines Sales by Region
      • 3.5.2 Asia Pacific Therapeutic Vaccines Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Therapeutic Vaccines Market Facts & Figures by Country
      • 3.6.1 Latin America Therapeutic Vaccines Sales by Country
      • 3.6.2 Latin America Therapeutic Vaccines Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa Therapeutic Vaccines Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Therapeutic Vaccines Sales by Country
      • 3.7.2 Middle East and Africa Therapeutic Vaccines Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global Therapeutic Vaccines Historic Market Analysis by Type

    • 4.1 Global Therapeutic Vaccines Sales Market Share by Type (2015-2020)
    • 4.2 Global Therapeutic Vaccines Revenue Market Share by Type (2015-2020)
    • 4.3 Global Therapeutic Vaccines Price Market Share by Type (2015-2020)
    • 4.4 Global Therapeutic Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global Therapeutic Vaccines Historic Market Analysis by Application

    • 5.1 Global Therapeutic Vaccines Sales Market Share by Application (2015-2020)
    • 5.2 Global Therapeutic Vaccines Revenue Market Share by Application (2015-2020)
    • 5.3 Global Therapeutic Vaccines Price by Application (2015-2020)

    6 Company Profiles and Key Figures in Therapeutic Vaccines Business

    • 6.1 Northeast Biotherapeutics
      • 6.1.1 Corporation Information
      • 6.1.2 Northeast Biotherapeutics Description, Business Overview and Total Revenue
      • 6.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 Northeast Biotherapeutics Products Offered
      • 6.1.5 Northeast Biotherapeutics Recent Development
    • 6.2 Agenus
      • 6.2.1 Agenus Therapeutic Vaccines Production Sites and Area Served
      • 6.2.2 Agenus Description, Business Overview and Total Revenue
      • 6.2.3 Agenus Therapeutic Vaccines Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 Agenus Products Offered
      • 6.2.5 Agenus Recent Development
    • 6.3 Vaccinogen Inc
      • 6.3.1 Vaccinogen Inc Therapeutic Vaccines Production Sites and Area Served
      • 6.3.2 Vaccinogen Inc Description, Business Overview and Total Revenue
      • 6.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 Vaccinogen Inc Products Offered
      • 6.3.5 Vaccinogen Inc Recent Development
    • 6.4 CIMAB S.A
      • 6.4.1 CIMAB S.A Therapeutic Vaccines Production Sites and Area Served
      • 6.4.2 CIMAB S.A Description, Business Overview and Total Revenue
      • 6.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 CIMAB S.A Products Offered
      • 6.4.5 CIMAB S.A Recent Development
    • 6.5 Dendreon
      • 6.5.1 Dendreon Therapeutic Vaccines Production Sites and Area Served
      • 6.5.2 Dendreon Description, Business Overview and Total Revenue
      • 6.5.3 Dendreon Therapeutic Vaccines Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 Dendreon Products Offered
      • 6.5.5 Dendreon Recent Development
    • 6.6 Corixa
      • 6.6.1 Corixa Therapeutic Vaccines Production Sites and Area Served
      • 6.6.2 Corixa Description, Business Overview and Total Revenue
      • 6.6.3 Corixa Therapeutic Vaccines Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 Corixa Products Offered
      • 6.6.5 Corixa Recent Development
    • 6.7 AVAX Technologies
      • 6.6.1 AVAX Technologies Therapeutic Vaccines Production Sites and Area Served
      • 6.6.2 AVAX Technologies Description, Business Overview and Total Revenue
      • 6.6.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 AVAX Technologies Products Offered
      • 6.7.5 AVAX Technologies Recent Development

    7 Therapeutic Vaccines Manufacturing Cost Analysis

    • 7.1 Therapeutic Vaccines Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Therapeutic Vaccines
    • 7.4 Therapeutic Vaccines Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Therapeutic Vaccines Distributors List
    • 8.3 Therapeutic Vaccines Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global Therapeutic Vaccines Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Therapeutic Vaccines by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of Therapeutic Vaccines by Type (2021-2026)
    • 10.2 Therapeutic Vaccines Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Therapeutic Vaccines by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of Therapeutic Vaccines by Application (2021-2026)
    • 10.3 Therapeutic Vaccines Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Therapeutic Vaccines by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of Therapeutic Vaccines by Region (2021-2026)
    • 10.4 North America Therapeutic Vaccines Estimates and Projections (2021-2026)
    • 10.5 Europe Therapeutic Vaccines Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific Therapeutic Vaccines Estimates and Projections (2021-2026)
    • 10.7 Latin America Therapeutic Vaccines Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa Therapeutic Vaccines Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      The global Therapeutic Vaccines market is valued at xx million US$ in 2020 is expected to reach xx million US$ by the end of 2026, growing at a CAGR of xx% during 2021-2026.
      This report focuses on Therapeutic Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Therapeutic Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
      Market Segment Analysis
      The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
      Segment by Type, the Therapeutic Vaccines market is segmented into
      Peptide Therapeutic Vaccine
      Cell Therapeutic Vaccine
      Nucleic Acid Therapeutic Vaccine

      Segment by Application
      Oncotherapy
      Hepatitis B
      Tuberculosis
      Herpes Simplex Virus
      Others

      Global Therapeutic Vaccines Market: Regional Analysis
      The Therapeutic Vaccines market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
      The key regions covered in the Therapeutic Vaccines market report are:
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      U.A.E
      Global Therapeutic Vaccines Market: Competitive Analysis
      This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
      The major players in global Therapeutic Vaccines market include:
      Northeast Biotherapeutics
      Agenus
      Vaccinogen Inc
      CIMAB S.A
      Dendreon
      Corixa
      AVAX Technologies

      Buy now